340 related articles for article (PubMed ID: 22066465)
1. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
3. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis.
OuYang D; Xu J; Huang H; Chen Z
Appl Biochem Biotechnol; 2011 Sep; 165(1):148-54. PubMed ID: 21505807
[TBL] [Abstract][Full Text] [Related]
5. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
8. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
9. Absolute quantification of metabolites in breast cancer cell extracts by quantitative 2D (1) H INADEQUATE NMR.
Martineau E; Tea I; Akoka S; Giraudeau P
NMR Biomed; 2012 Aug; 25(8):985-92. PubMed ID: 22331830
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Zhang L; Jin H; Guo X; Yang Z; Zhao L; Tang S; Mo P; Wu K; Nie Y; Pan Y; Fan D
Clin Biochem; 2012 Sep; 45(13-14):1064-9. PubMed ID: 22613268
[TBL] [Abstract][Full Text] [Related]
11. Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification.
Bertram HC; Eggers N; Eller N
Anal Chem; 2009 Nov; 81(21):9188-93. PubMed ID: 19780580
[TBL] [Abstract][Full Text] [Related]
12. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
Lin X; Zhan B; Wen S; Li Z; Huang H; Feng J
Mol Biosyst; 2016 Aug; 12(9):2883-92. PubMed ID: 27400832
[TBL] [Abstract][Full Text] [Related]
13. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
[TBL] [Abstract][Full Text] [Related]
14. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
[TBL] [Abstract][Full Text] [Related]
15. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.
Mavel S; Nadal-Desbarats L; Blasco H; Bonnet-Brilhault F; Barthélémy C; Montigny F; Sarda P; Laumonnier F; Vourc'h P; Andres CR; Emond P
Talanta; 2013 Sep; 114():95-102. PubMed ID: 23953447
[TBL] [Abstract][Full Text] [Related]
16. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
Feng J; Liu H; Zhang L; Bhakoo K; Lu L
Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.
Hwang TL; Liang Y; Chien KY; Yu JS
Proteomics; 2006 Apr; 6(7):2259-72. PubMed ID: 16493704
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fingerprinting of Tussilago farfara L. using ¹H-NMR spectroscopy and multivariate data analysis.
Zhi HJ; Qin XM; Sun HF; Zhang LZ; Guo XQ; Li ZY
Phytochem Anal; 2012; 23(5):492-501. PubMed ID: 22371211
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy.
Li JV; Holmes E; Saric J; Keiser J; Dirnhofer S; Utzinger J; Wang Y
Int J Parasitol; 2009 Apr; 39(5):547-58. PubMed ID: 19068218
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.
Bertini I; Cacciatore S; Jensen BV; Schou JV; Johansen JS; Kruhøffer M; Luchinat C; Nielsen DL; Turano P
Cancer Res; 2012 Jan; 72(1):356-64. PubMed ID: 22080567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
